文章摘要
慢性乙型肝炎患者用药依从性个体化预测模型的建立与验证
Establishment and validation of model for individualized prediction of medication compliance in patients with chronic hepatitis B
  
DOI:10.3969/j.issn.1007-8134.2021.05.006
中文关键词: 慢性乙型肝炎  抗病毒药物  个体化预测  用药依从性  危险因素  列线图  临床预警  模型验证
英文关键词: chronic hepatitis B  antiviral drug  individualized prediction  medication compliance  risk factor  nomogram  clinical warning  model verification
基金项目:2018年度安徽高校自然科学研究项目(KJ2018C0396)
作者单位
任菲菲 阜阳市第二人民医院药剂科 
姚雷娜 阜阳市第二人民医院药剂科 
摘要点击次数: 441
全文下载次数: 483
中文摘要:
      目的 建立慢性乙型肝炎(慢乙肝)患者用药依从性个体化预测模型并进行验证,为慢乙肝患者用药提供依据。方法 选取2019年11月—2021年4月于我院门诊就诊的235例慢乙肝患者作为研究对象,收集患者临床资料等数据,采用单因素和多因素Logistic回归分析分析影响用药依从性的因素,进而建立相关列线图模型。结果 年龄≥60岁、文化程度低、未定期在同一门诊随访、未接受过乙肝用药健康教育、医疗支付方式为自费、服药种类≥3种和有药物不良反应是慢乙肝患者用药依从性差的危险因素(P均<0.05)。列线图模型验证结果显示训练集和验证集的C-index分别为0.811(95%CI:0.787~0.833)和0.802(95%CI:0.781~0.822),校正曲线均趋近于理想曲线,AUC分别为0.830(95%CI:0.804~0.872)和0.816(95%CI:0.797~0.834)。结论 年龄≥60岁、文化程度低、未定期在同一门诊随访、未接受过乙肝用药健康教育、自费支付、服药种类≥3种和有药物不良反应是与慢乙肝患者用药依从性差密切相关的危险因素,据此构建的列线图模型能够有效预测慢乙肝患者用药依从性差的风险,对提高慢乙肝患者遵医行为和增强治疗效果具有重要意义。
英文摘要:
      Objective To establish and validate a model for individualized prediction of medication compliance in patients with chronic hepatitis B. Methods A total of 235 patients with chronic hepatitis B treated in outpatient department of our hospital from November 2019 to April 2021 were selected as the research objects. The clinical data of patients were collected, the influencing factors of medication compliance were analyzed by single factor and Logistic regression, and the relevant nomogram model was established. Results Age ≥60 years, low education level, failure of regular follow-up visits in the same clinic, no health education on hepatitis B medication, self-payment for medical cost, ≥3 drugs administered and presence of adverse drug reactions were the risk factors for poor medication compliance of patients with chronic hepatitis B (P<0.05). The results of nomogram model validation showed that the C-index of the training set and the validation set were 0.811 (95%CI: 0.787-0.833) and 0.802 (95%CI: 0.781-0.822), respectively. The calibration curve was close to the ideal curve. The AUC of the ROC curve was 0.830 (95%CI: 0.804-0.872) and 0.816 (95%CI: 0.797-0.834), respectively. Conclusions Age ≥60 years, low education level, failure of regular follow-up visits in the same clinic, no health education on hepatitis B medication, self-payment for medical cost, ≥3 drugs administered and presence of adverse drug reactions are the risk factors closely related to poor medication compliance in patients with chronic hepatitis B. Accordingly, the established nomogram model can effectively predict the risk of poor medication compliance in patients with chronic hepatitis B, which is of great significance for improving the compliance behavior of patients with chronic hepatitis B and enhancing the treatment effect.
HTML   查看全文   下载PDF阅读器
关闭